×
About 18,032 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  7,557 results

Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between...
https://doi.org/10.1002/msc.1513
Musculoskeletal Care; Kelly K

Sep 19th, 2020 - This study explored the psychological impact of living with chronic pain as a result of ankylosing spondylitis or undifferentiated spondyloarthritis. The aim was to investigate individual's current pain experience and their current psychological s...

Functional MR imaging beyond structure and inflammation-radiographic axial spondyloarth...
https://doi.org/10.1186/s13075-020-02312-x
Arthritis Research & Therapy; Abrar DB, Schleich C et. al.

Sep 18th, 2020 - To compare the glycosaminoglycan (GAG) content of lumbar intervertebral disks (IVDs) of patients with ankylosing spondylitis (AS) and healthy volunteers and to investigate the association of GAG depletion and disease-related clinical and imaging f...

Ankylosing Spondylitis With Bilateral Symmetrical Uptake in the Greater Trochanters on ...
https://doi.org/10.1097/RLU.0000000000003304
Clinical Nuclear Medicine; Marashdeh WM, Alsa'di HS et. al.

Sep 18th, 2020 - Ankylosing spondylitis is a chronic inflammatory bone disease that commonly affects the spine and the sacroiliac joints. Ankylosing spondylitis can also cause enthesitis, or enthesopathy, which is an inflammation at the tendinous or ligamentous in...

Unexpected increase of aortic stiffness in juvenile Spondyloarthropathies.
https://doi.org/10.1017/S1047951120002796
Cardiology in the Young; Dedeoglu R, Yildiz M et. al.

Sep 17th, 2020 - Juvenile spondyloarthropathy is an umbrella term for a group of childhood rheumatic diseases that can cause chronic arthritis extending to the axial skeleton before the age of 16. Although ankylosing spondylitis has aortic involvement as one of it...

Radiographic predictive findings of neck pain in patients with ankylosing spondylitis.
https://doi.org/10.1080/02688697.2020.1820947
British Journal of Neurosurgery; Cho JY, Park W et. al.

Sep 17th, 2020 - The aim of this study was to investigate the relationship between neck pain and radiological findings in ankylosing spondylitis (AS) patients. The study groups comprised 257 AS and 50 normal patients. Of the AS patients, 91 had axial neck pain (gr...

see more →

Guidelines  37 results

2019 Update of the American College of Rheumatology/ Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis ...
https://www.rheumatology.org/Portals/0/Files/AxialSpA-Guideline-2019.pdf
Ward MM,et al

Sep 30th, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). ankylosing spondylitis

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.) References; Ward MM, Deodhar A et. al.

Aug 22nd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
https://www.businesswire.com/news/home/20190723006033/en/FDA-Approves-Samsung-Bioepis-HADLIMA%E2%84%A2-adalimumab-bwwd

Jul 23rd, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthr...

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States
http://www.samsungbioepis.com/en/newsroom/detail/FDA-Approves-ETICOVO-Samsung-Bioepis-Second-Anti-TNF-Medicine.html

Apr 28th, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthri...

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guidelin...
https://www.rheumatology.org/Portals/0/Files/ACR-AAHKS-Perioperative-Management-Guideline.pdf
Goodman, S.,et al

Jul 31st, 2017 - This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid a.

see more →

Drugs  1,005 results see all →

Clinicaltrials.gov  8,835 results

Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between...
https://doi.org/10.1002/msc.1513
Musculoskeletal Care; Kelly K

Sep 19th, 2020 - This study explored the psychological impact of living with chronic pain as a result of ankylosing spondylitis or undifferentiated spondyloarthritis. The aim was to investigate individual's current pain experience and their current psychological s...

Functional MR imaging beyond structure and inflammation-radiographic axial spondyloarth...
https://doi.org/10.1186/s13075-020-02312-x
Arthritis Research & Therapy; Abrar DB, Schleich C et. al.

Sep 18th, 2020 - To compare the glycosaminoglycan (GAG) content of lumbar intervertebral disks (IVDs) of patients with ankylosing spondylitis (AS) and healthy volunteers and to investigate the association of GAG depletion and disease-related clinical and imaging f...

Ankylosing Spondylitis With Bilateral Symmetrical Uptake in the Greater Trochanters on ...
https://doi.org/10.1097/RLU.0000000000003304
Clinical Nuclear Medicine; Marashdeh WM, Alsa'di HS et. al.

Sep 18th, 2020 - Ankylosing spondylitis is a chronic inflammatory bone disease that commonly affects the spine and the sacroiliac joints. Ankylosing spondylitis can also cause enthesitis, or enthesopathy, which is an inflammation at the tendinous or ligamentous in...

Unexpected increase of aortic stiffness in juvenile Spondyloarthropathies.
https://doi.org/10.1017/S1047951120002796
Cardiology in the Young; Dedeoglu R, Yildiz M et. al.

Sep 17th, 2020 - Juvenile spondyloarthropathy is an umbrella term for a group of childhood rheumatic diseases that can cause chronic arthritis extending to the axial skeleton before the age of 16. Although ankylosing spondylitis has aortic involvement as one of it...

Radiographic predictive findings of neck pain in patients with ankylosing spondylitis.
https://doi.org/10.1080/02688697.2020.1820947
British Journal of Neurosurgery; Cho JY, Park W et. al.

Sep 17th, 2020 - The aim of this study was to investigate the relationship between neck pain and radiological findings in ankylosing spondylitis (AS) patients. The study groups comprised 257 AS and 50 normal patients. Of the AS patients, 91 had axial neck pain (gr...

see more →

News  547 results

UK's Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients
https://www.reuters.com/article/us-health-coronavirus-therapy-izana/uks-izana-bioscience-tests-rheumatoid-arthritis-drug-in-covid-19-patients-idUSKBN21N0Z9

Apr 5th, 2020 - LONDON (Reuters) - UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo and Milan in Italy. Nami...

TNFi treatment shows hint of slowing axial spondyloarthritis radiographic progression
https://www.mdedge.com/rheumatology/article/215946/ankylosing-spondylitis/tnfi-treatment-shows-hint-slowing-axial?channel=299
Jeff Evans

Jan 22nd, 2020 - Tumor necrosis factor inhibitors may slow radiographic progression in the spine of patients with ankylosing spondylitis after at least 4 years of use, according to an analysis of studies with low risk of bias, but no evidence exists for slowed dis.

FDA approves infliximab-axxq for numerous indications
https://www.mdedge.com/familymedicine/article/213759/rheumatoid-arthritis/fda-approves-infliximab-axxq-numerous-indications?channel=39313
MDedge Rheumatology; Christopher Palmer

Dec 6th, 2019 - The Food and Drug Administration has approved the biosimilar infliximab-axxq (Avsola) for various indications, making it the fourth biosimilar of infliximab (Remicade) to be cleared for marketing by the agency. Wikimedia Commons/FitzColinGerald/ C.

see more →

Patient Education  51 results see all →